NeoCura

Changping, China Founded: 2017 • Age: 9 yrs
AI-enabled platforms for tumor diagnosis and immunotherapy are developed.
Request Access

About NeoCura

NeoCura is a company based in Changping (China) founded in 2017 by Wang Yi.. NeoCura has raised $38.19 million across 2 funding rounds from investors including CDH, PICC Capital Investment Management and Jiayin Fund. NeoCura operates in a competitive market with competitors including Strand Life Sciences, Helix, Benchling, BioAge Labs and Scholar Rock, among others.

  • Headquarter Changping, China
  • Founders Wang Yi
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $38.19 M (USD)

    in 2 rounds

  • Latest Funding Round
  • Investors
    CDH

    & 6 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of NeoCura

NeoCura has successfully raised a total of $38.19M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round
  • First Round

    (23 Dec 2020)

  • Investors Count 7
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2021 Amount Series A - NeoCura Valuation CDH , PICC Capital Investment Management
Dec, 2020 Amount Series A - NeoCura Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in NeoCura

NeoCura has secured backing from 7 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include CDH, PICC Capital Investment Management and Jiayin Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Private equity and private debt firm focused on multiple sectors
Founded Year Domain Location
-
Founded Year Domain Location
Venture capital firm
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by NeoCura

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - NeoCura

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Neocura Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of NeoCura

NeoCura operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Strand Life Sciences, Helix, Benchling, BioAge Labs and Scholar Rock, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
domain founded_year HQ Location
Genomic database for clinical research is provided.
domain founded_year HQ Location
Cloud-based bioinformatics platform is offered for biotech research.
domain founded_year HQ Location
Bioinformatics platform is provided for biomarkers and drug discovery.
domain founded_year HQ Location
Antibody-based drugs for primary myopathies are developed and targeted.
domain founded_year HQ Location
Genomic data is analyzed and interpreted via web-based applications.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Neocura

Frequently Asked Questions about NeoCura

When was NeoCura founded?

NeoCura was founded in 2017 and raised its 1st funding round 3 years after it was founded.

Where is NeoCura located?

NeoCura is headquartered in Changping, China. It is registered at Changping, Beijing, China.

Who is the current CEO of NeoCura?

Wang Yi is the current CEO of NeoCura. They have also founded this company.

Is NeoCura a funded company?

NeoCura is a funded company, having raised a total of $38.19M across 2 funding rounds to date. The company's 1st funding round was a Series A of $38.19M, raised on Dec 23, 2020.

What does NeoCura do?

NeoCura was founded in 2017 in Changping, China, within the biotechnology sector. Operations focus on AI-integrated platforms that analyze molecular and clinical data for cancer diagnostics and precision medicine. Key offerings include NeoCura for blood-based cancer detection, NeoCura Vac for neoantigen therapeutics guided by AI, and NeoCura Info for multi-omics bioinformatics services. These tools support tumor identification and treatment strategies.

Who are the top competitors of NeoCura?

NeoCura's top competitors include Strand Life Sciences, Helix and Benchling.

Who are NeoCura's investors?

NeoCura has 7 investors. Key investors include CDH, PICC Capital Investment Management, Jiayin Fund, Zhou Yahui, and IDG Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available